In the lab
We undertake the basic science to produce novel molecules and compounds that will act as alternatives to the current limited “medicine cabinet” of antibiotics.
Preventing the unthinkable from becoming the inevitable
About
The Ineos Oxford Institute for Antimicrobial Research (IOI) was established at the University of Oxford in January 2021 to advance research, education and collaboration in search of solutions to one of the biggest public health challenges of our time.
Our mission is to lead science that will enable the development new of antibiotics and provide the evidence to support transformational change in how we address antimicrobial resistance, to prevent the unthinkable from becoming the inevitable.
The IOI operates under three main pillars of activity:
In the field
We survey, model and assess the global AMR burden to discover new ways to prevent and treat drug-resistant infections.
With the public
We work with government, industry and practitioners worldwide to inform citizens and galvanise actions that will prevent the spread of antimicrobial resistance.
Research Focus
Research
The IOI has three primary, interconnected research programmes, which in turn feed into its education and policy work.
What is AMR?
This area is linked to another screen. To quickly view links and navigate to linked screens, hold down Shift.
Oxford tackling AMR
Oxford is home to world-class academic talent, research infrastructure and international networks.
About the Institute
Our Approach
Our mission is to drive transformational global progress in tackling AMR.
Our People
We are a cross-disciplinary team of scientists and professionals dedicated to combatting AMR.
INEOS: Our Benefactor
INEOS has long been passionate about public health, and its trio of owners are determined to join the fight against AMR.